-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

627.O1.6 627. Aggressive Lymphomas: Clinical and Epidemiological: Population data for Aggressive NHL Management

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Epidemiology, Lymphomas, non-Hodgkin lymphoma, Workforce, Health Outcomes Research, Diseases, Real World Evidence, aggressive lymphoma, Registries, Lymphoid Malignancies
Saturday, December 11, 2021: 9:30 AM-11:00 AM
Georgia Ballroom 1-3 (Georgia World Congress Center)
Moderators:
Oreofe O. Odejide, MD, MPH, Dana-Farber Cancer Institute and Toby A. Eyre, Oxford University Hospitals NHS Foundation Trust
Disclosures:
Eyre: Roche: Consultancy, Honoraria; Gilead/KITE: Honoraria, Other: Travel support for conferences, Research Funding, Speakers Bureau; Janssen: Honoraria; Abbvie: Consultancy, Honoraria, Other: Travel to conferences; AstraZeneca: Honoraria, Research Funding; Loxo Oncology: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Beigene: Honoraria, Research Funding; Incyte: Consultancy; Secura Bio: Consultancy, Honoraria.
This session will present and discuss high quality, clinically relevant population based DLBCL data
9:30 AM

Daniel A. Ermann, MD1, Victoria A. Vardell, MD2, Harsh Shah, DO3, Randa Tao, MD4*, David K. Gaffney, MD4*, Deborah M. Stephens5 and Boyu Hu, MD5

1Department of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Omaha, NE
2Department of Internal Medicine, University of Utah, Salt Lake City, UT
3Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT
4Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
5Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

9:45 AM

Jordan Carter, MD1, Adam J. Olszewski, MD2, Tatyana A. Feldman, MD3, Reem Karmali, MD, MSc4, Jean L. Koff, MD, MSc5, Sabarish Ayyappan, MBBS6, Matthew A. Lunning, DO, FACP7, Shazia Nakohda, MD8*, Nadia Khan, MD8, Aryeh Pelcovits, MD9, Jason Lofters, MD3*, Timothy Seijung Oh, MD4*, Colin Burke O'Leary, MA10*, Kittika Poonsombudlert, MD11, Carman Tong12*, Elaine Kuhn, MD13*, Mingen Liu, MD, PhD14*, Andrea Anampa-Guzman, MD15*, Megha Shalavadi, MD16*, Colin Thomas, MD17*, Melissa Kives18*, Ning C. Dong, MD19, Alexander Hershey, MD1*, Neil Palmisiano, MD20, Alexey V. Danilov, MD, PhD16, Francisco J. Hernandez-Ilizaliturri, MD21, Stefan K. Barta, MD22, Frederick Lansigan, MD13, Kerry J. Savage, MD, MSc, FRCPC23 and Andrew M. Evens, DO, MMSc1

1Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
2Lifespan Cancer Institute, Alpert Medical School of Brown University, Providence, RI
3John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
4Division of Hematology and Oncology, Northwestern University, Chicago, IL
5Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
6Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
7Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE
8Fox Chase Cancer Center, Philadelphia, PA
9Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI
10Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
11Holden Comprehensive Cancer Center, University of Iowa Hospital and Clinics, Iowa city, IA
12Clinical Trials Unit, BC Cancer, Vancouver, BC, Canada
13Dartmouth-Hitchcock Medical Center, Lebanon, NH
14University of Pennsylvania, Philadelphia, PA
15Roswell Park Comprehensive Cancer Center, Buffalo, NY
16City of Hope Toni Stephenson Lymphoma Center, Duarte, CA
17Thomas Jefferson University, Philadelphia, PA
18Emory University, Atlanta, GA
19Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
20Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
21Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
22Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
23BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada

10:00 AM

Andreas K. Oevlisen, MD, PhD1,2*, Lasse H. Jakobsen, MSc, PhD1,2*, Kristian Hay Kragholm, MD3*, René Ernst Nielsen, Professor, MD4,5*, Peter De Nully Brown, MD6, Rasmus Bo Dahl-Soerensen, MD7*, Henrik Frederiksen, M.D., Ph.D.8*, Nikolaj Mannering8*, Pär L. Josefsson, MD9, Ahmed Al-Mashhadi, MD10*, Judit M. Jørgensen, MD, PhD11*, Andriette Dessau-Arp, MD12*, Michael Roost Clausen, MD, PhD13*, Robert Schou Pedersen, MD, PhD14*, Christian Torp-Pedersen, MD15*, Marianne Tang Severinsen, MD, PhD1,2* and Tarec Christoffer Christoffer El-Galaly, MD, DSc1,2

1Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
2Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
3Unit of Clinical Biostatistics and Epidemiology, Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
4Department of Psychiatry, Aalborg University Hospital, Aalborg, Denmark
5Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark
6Dept. of Hematology, Rigshospitalet, Copenhagen, Denmark
7Department of Hematology, Roskilde Sygehus, Roskilde, Denmark
8Department of Hematology, Odense University Hospital, Odense, Denmark
9Department of Hematology, Copenhagen University Hospital (Rigshospitalet), Herlev, Denmark
10Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
11Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
12Department of Hematology, Sydvestjysk Hospital, Esbjerg, Denmark
13Department of Haematology, Vejle Hospital, Vejle, Denmark
14Department of Hematology, Holstebro Hospital, Holstebro, Denmark
15Department of Cardiology, Nordsjaellands Hospital, Hillerød, Denmark

10:15 AM

Anita Kumar, MD1, Jason R. Westin, MD2, Stephen J. Schuster, MD3, Grzegorz S. Nowakowski, MD4, Izidore S. Lossos, MD5, Devin Copley6*, Clare Grieve7*, Allison P. Jacob8*, Ashlee Joseph7*, Leana Laraque, BA7*, Gita Masand2*, Chelsea D Mullins, BS8*, Ellen Napier, CRNP9*, Tania Rodriguez10*, Venkatraman Seshan, PhD11*, Shreya Vemuri12* and Andrew D. Zelenetz, MD, PhD7

1Department of Medicine, M, Short Hills, NJ
2MD Anderson Cancer Center, Houston, TX
3Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
4Division of Hematology, Mayo Clinic, Rochester, MN
5Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
6Mayo Clinic, Rochester, MN
7Memorial Sloan Kettering Cancer Center, New York, NY
8Adaptive Biotechnologies, Seattle, WA
9Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
10Sylvester Comprehensive Cancer Center - University of Miami, Miami, FL
11Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
12Sloan Kettering Institute, 1275 York Avenue, NY

10:30 AM

Freja Tang Severinsen, BSc1*, Laura Mors Haunstrup, MD2*, Rasmus Kuhr Jensen2*, Matthew J. Maurer, MS, DMSc3*, Arushi Khurana, M.B.B.S.4*, Paw Jensen, MD2*, Judit M. Jørgensen, MD, PhD5*, Thomas Stauffer Larsen6*, Michael Roost Clausen, MD, PhD7*, Christian Bjørn Poulsen, MD8*, Peter de Nully Brown, MD, PhD9*, Tarec Christoffer Christoffer El-Galaly, MD, DSc10,11 and Lasse H. Jakobsen, MSc, PhD10,11*

1Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, AL, Denmark
2Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
3Department of Health Sciences Research, Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester, MN
5Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
6Department of Hematology, Odense University Hospital, Odense C, Denmark
7Department of Haematology, Vejle Hospital, Vejle, Denmark
8Department of Haematology, Zealand University Hospital, Roskilde, Denmark
9Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
10Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
11Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

10:45 AM

Carmelo Carlo-Stella, MD1, Pier Luigi Zinzani, MD2, Murali Janakiram, MD, MS3*, Vivian Dai, MD4*, Xiaomin He, PhD4*, Annette Ervin-Haynes, DO, MPA4* and Julien Depaus, MD5*

1Department of Biomedical Sciences, Humanitas University, and Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Milan, Italy
2IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli” and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
3University of Minnesota, Minneapolis, MN
4Clinical Development, ADC Therapeutics America, Inc., Murray Hill, NJ
5Department of Hematology, CHU UCL Namur site Godinne, Yvoir, Belgium

*signifies non-member of ASH